Загрузка...
The design and development of covalent protein-protein interaction inhibitors for cancer treatment
Protein-protein interactions (PPIs) are central to a variety of biological processes, and their dysfunction is implicated in the pathogenesis of a range of human diseases, including cancer. Hence, the inhibition of PPIs has attracted significant attention in drug discovery. Covalent inhibitors have...
Сохранить в:
| Опубликовано в: : | J Hematol Oncol |
|---|---|
| Главные авторы: | , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
BioMed Central
2020
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7106679/ https://ncbi.nlm.nih.gov/pubmed/32228680 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13045-020-00850-0 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|